Pharmacology · MU Sofia

49. Haemostatics (antihemorrhagic) drugs

Covers haemostatic drugs that stop or control bleeding, grouping them into antifibrinolytics, clotting factor concentrates, platelet aggregation inhibitors, desmopressin and vitamin K. For each group it gives the mechanism, a pharmacokinetics table, common and rare side effects, drug interactions, therapeutic uses, and pregnancy considerations, ending with recap questions.

Inside: 9 sections · 6 labelled pictures · 1 table · 10 flashcards · 3 min

Topic 48 of 93 in the MU Sofia syllabus for Pharmacology (Medicine, Year 3). The free AceMed note covers it in 9 sections, about 398 words (3 min of reading), with 10 flashcards.

In this note

  1. Hemostatic (Antihemorrhagic) Drugs
  2. Classification
  3. Pharmacodynamics (Mechanism of Action)
  4. Pharmacokinetics
  5. Side Effects
  6. Drug Interactions
  7. Therapeutic Uses
  8. Pregnancy & Lactation Considerations
  9. Key Recap Questions

Hemostatic (Antihemorrhagic) Drugs

Hemostatic drugs, also known as antihemorrhagic drugs, are medications used to stop or control bleeding. They promote clot formation or prevent excessive bleeding in medical conditions, surgeries, or injuries.

Classification

  1. 1. Antifibrinolytics: Tranexamic acid, Aminocaproic acid
  2. 2. Clotting Factors: Factor VIII concentrate, Factor IX concentrate
  3. 3. Platelet Aggregation Inhibitors: Aspirin, Clopidogrel
  4. 4. Desmopressin (DDAVP)
  5. 5. Vitamin K

Pharmacodynamics (Mechanism of Action)

  1. 1. Antifibrinolytics:
  • Block plasmin activity, preventing fibrin clot breakdown.
  • Enhance clot stability, promoting hemostasis.
  1. 2. Clotting Factor Concentrates:
  • Replace deficient clotting factors in conditions like hemophilia.
  • Improve blood coagulation and reduce bleeding episodes.
  1. 3. Platelet Aggregation Inhibitors:
  • Prevent platelet aggregation, reducing excessive clot formation.
  • Used to prevent thrombotic events (e.g., heart attacks, strokes).
  1. 4. Desmopressin (DDAVP):
  • Stimulates release of von Willebrand factor and Factor VIII.
  • Enhances platelet adhesion and coagulation.
  1. 5. Vitamin K:
  • Essential for synthesis of clotting factors II (prothrombin), VII, IX, X.
  • Improves blood coagulation in conditions like vitamin K deficiency or warfarin overdose.

Continue reading free

The whole note, all 9 sections, is free with an AceMed account, with its 10 flashcards. Premium adds flashcard recall, highlights and Ask AI.